Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Fractyl Health Inc (NASDAQ: GUTS) closed the day trading at $1.01 down -45.99% from the previous closing price of $1.87. In other words, the price has decreased by -$45.99 from its previous closing price. On the day, 8.78 million shares were traded. GUTS stock price reached its highest trading level at $1.05 during the session, while it also had its lowest trading level at $0.825.
Ratios:
For a better understanding of GUTS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.50. In the meantime, Its Debt-to-Equity ratio is 9.63 whereas as Long-Term Debt/Eq ratio is at 8.84.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.
On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 91586296 and an Enterprise Value of 68783400. For the stock, the TTM Price-to-Sale (P/S) ratio is 824.47 while its Price-to-Book (P/B) ratio in mrq is 7.75. Its current Enterprise Value per Revenue stands at 1146.39 whereas that against EBITDA is -0.718.
Stock Price History:
The Beta on a monthly basis for GUTS is 1.56, which has changed by -0.44505495 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.72, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -44.66%, while the 200-Day Moving Average is calculated to be -44.01%.
Shares Statistics:
Over the past 3-months, GUTS traded about 524.26K shares per day on average, while over the past 10 days, GUTS traded about 1510320 shares per day. A total of 48.92M shares are outstanding, with a floating share count of 20.88M. Insiders hold about 57.37% of the company’s shares, while institutions hold 33.09% stake in the company. Shares short for GUTS as of 1752537600 were 1889593 with a Short Ratio of 3.60, compared to 1749772800 on 2486895. Therefore, it implies a Short% of Shares Outstanding of 1889593 and a Short% of Float of 7.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
